AMZN
Amazon.com, Inc.
AMZN has the edge over DIBS overall, supported by lower modeled downside and stronger valuation.
DIBS
1stdibs.Com, Inc.
DIBS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
DIBS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Unavailable |
DIBS's revenue and cash flow are currently stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
DIBS PE Valuation
DIBS has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over DIBS on the outlook, with more favorable earnings and revenue expectations.
DIBS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect DIBS's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over DIBS on earnings quality, reporting a profit while its opponent remains loss making.
DIBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.15 | +$0.35 |
| Q2 2026 | -$0.21 | +$0.34 |
| Q1 2026 | -$0.30 | +$0.25 |
| Q4 2025 | -$0.38 | +$0.11 |
| Q3 2025 | -$0.50 | -$0.08 |
| Q2 2025 | -$0.55 | -$0.20 |
| Q1 2025 | -$0.55 | -$0.11 |
| Q4 2024 | -$0.49 | +$0.08 |
DIBS is still losing money, but far less than before: $0.15 per share over the past year, against $0.83 at its worst in mid-2023.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over DIBS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over DIBS on profitability, with a higher operating margin.
DIBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.1M | +5.1% |
| Q2 2026 | $23.3M | +5.3% |
| Q1 2026 | $22.4M | -0.7% |
| Q4 2025 | $23M | +0.9% |
| Q3 2025 | $22M | +3.7% |
| Q2 2025 | $22.1M | -0.4% |
| Q1 2025 | $22.5M | +2.2% |
| Q4 2024 | $22.8M | +8.8% |
DIBS's revenue grew through 2022 and has held roughly level since: $23M last quarter, up 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -9.8% | +12 points |
| Q2 2026 | -8.8% | +17 points |
| Q1 2026 | -15% | +13 points |
| Q4 2025 | -10% | +21 points |
| Q3 2025 | -21% | +14 points |
| Q2 2025 | -26% | +3.4 points |
| Q1 2025 | -28% | -3.5 points |
| Q4 2024 | -31% | -5.9 points |
DIBS's operating margin was −9.8% last quarter, up 12 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
DIBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.9M | +$4.4M |
| Q2 2026 | -$5.1M | +$121K |
| Q1 2026 | $827K | +$970K |
| Q4 2025 | $3.6M | +30% |
| Q3 2025 | -$1.5M | -$1.4M |
| Q2 2025 | -$5.2M | -$2.2M |
| Q1 2025 | -$143K | +$3.1M |
| Q4 2024 | $2.8M | +$4.9M |
DIBS has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
DIBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.1% | -727K shares |
| 1 year | -7.2% | -2.6M shares |
| 3 years | -16% | -6.2M shares |
| 5 years | +103% | +17.1M shares |
| Available history | +9.9% | +3M shares |
DIBS has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $11.6M |
| Q1 2026 | $9.1M |
| Q4 2025 | $1.6M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $1.8M |
| Q4 2024 | $5M |
DIBS spent $22M buying back its own shares over the past year, about three times what it spent the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
DIBS Net Leverage
DIBS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
DIBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.5 | Neutral |
| Stochastic | 87.5 | Overbought |
DIBS's weekly RSI is 63 (neutral) and its Stochastic is 88 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
DIBS PE vs Consumer Cyclical Sector
DIBS has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
DIBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.67 | 25% above |
| 20 week MA | $4.61 | 26% above |
| 50 week MA | $5.00 | 17% above |
| 100 week MA | $4.08 | 43% above |
| 200 week MA | $4.30 | 36% above |
DIBS has climbed back above all five of its weekly moving averages, and it's now 36% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over DIBS on returns for 2026, with the stronger performance.
DIBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.1 | $12.8 | -47% |
| 2022 | $12.8 | $5.00 | -61% |
| 2023 | $5.00 | $4.68 | -6.4% |
| 2024 | $4.68 | $3.69 | -21% |
| 2025 | $3.69 | $5.91 | +60% |
| 2026 YTD | $5.91 | $5.83 | -1.4% |
DIBS has finished lower in four of the last five years. It's down 1.4% so far in 2026.